| Product Information |
| Synonym(s) |
GSK-3 Inhibitor XVI |
| Chemical Name |
6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile |
| Application |
CHIR-99021 is a GSK-3α/β inhibitor |
| CAS Number |
252917-06-9 |
| Purity |
≥99.0% |
| Molecular Weight |
465.34 |
| Molecular Formula |
C₂₂H₁₈Cl₂N₈ |
| SMILES |
N#CC(C=N1)=CC=C1NCCNC2=NC=C(C3=NC(C)=CN3)C(C4=CC=C(Cl)C=C4Cl)=N2 |
| Target & IC50 |
GSK-3α: IC50 = 10 nM GSK-3β: IC50 = 6.7 nM |
| Solubility |
DMSO: 78 mg/mL (167.62 mM) |
| Preparing Stock Solutions |
| ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
| 1 mM |
2.1490 ml |
10.7448 ml |
21.4897 ml |
| 5 mM |
0.4298 ml |
2.1490 ml |
4.2979 ml |
| 10 mM |
0.2149 ml |
1.0745 ml |
2.1490 ml |
| 50 mM |
0.0430 ml |
0.2149 ml |
0.4298 ml |
|
| Shipping |
Gel Pack |
| Storage |
Store at -20°C |
| Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |